Dergiler / Journal of the Turkish-German Gynecological Association / 2019 / Cilt: 20 - Sayı: 2

Effects of mature cystic teratoma on reproductive health and malignant transformation: A retrospective analysis of 80 cases

Sayfa
84–88
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In MCT malignant degeneration, mass diameter, complex mass internal structure, and postmenopausal status are important factors. (J Turk Ger Gynecol Assoc 2019; 20: 84-8)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To examine cases of mature cystic teratoma (MCT) that were diagnosed and treated in our clinic regarding their association with fertility, and to detect the rate of malignant degeneration and the types of malignancies.Material and Methods: Patients who underwent surgery due to adnexal mass between April 2012 and August 2017 and were diagnosed as having MCT were retrospectively examined.
📊
Temel Bulgular & Veri:The mean age of the 80 patients who met the inclusion criteria was 30.60±10.5 years.
💡
Sonuç & Katkı:In MCT malignant degeneration, mass diameter, complex mass internal structure, and postmenopausal status are important factors. (J Turk Ger Gynecol Assoc 2019; 20: 84-8)
🔬Tür:Araştırma Makalesi
📍Kapsam:2012 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To examine cases of mature cystic teratoma (MCT) that were diagnosed and treated in our clinic regarding their association with fertility, and to detect the rate of malignant degeneration and the types of malignancies.Material and Methods: Patients who underwent surgery due to adnexal mass between April 2012 and August 2017 and were diagnosed as having MCT were retrospectively examined. The mean age of the 80 patients who met the inclusion criteria was 30.60±10.5 years. Nine had infertility according to hospital records. Sixty-seven percent of these (n=6) had accompanying endometriosis and MCT was bilateral in 55.5% (n=5). Malignant degeneration was present in 6.25% (n=5), all were monodermal tumors. Malignant degeneration was more common among patients with larger diameter adnexal masses (9.1±2.9 cm) and in those of postmenopausal age. Tumor markers were within the normal range for patients who developed malignancy. Malignant degeneration was not present among infertile patients with endometriosis.Results: Although MCTs do not seem to negatively affect the ovarian reserve, infertility is prominent in patients with concurrent endometriosis. During assessment, concurrent endometriosis should be considered. Imaging findings, large adnexal masses, and postmenopausal period are important for the assessment of MCT concerning malignant degeneration. It should not be overlooked because tumor markers may be normal.Conclusion: MCTs can be present concurrent with endometriomas. In such cases, infertility is more distinct. In MCT malignant degeneration, mass diameter, complex mass internal structure, and postmenopausal status are important factors. (J Turk Ger Gynecol Assoc 2019; 20: 84-8)

🔖

Bu Makaleye Atıf Yap

SAYGILI, U., SAATLİ, H. B., DOĞAN, Ö. E., AVŞAR, H. A., KURT, S. (2022). Effects of mature cystic teratoma on reproductive health and malignant transformation: A retrospective analysis of 80 cases. Journal of the Turkish-German Gynecological Association, Cilt: 20 - Sayı: 2, 84–88. https://ajindex.com/articles/567462

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Sherpa P, Baral R. A Clinicopathological Evaluation of 230 Cases of Mature Cystic Teratomas. NJOG 2016; 21: 51-3
  2. Ustunyurt E, Gungor T, Iskender C, Ustunyurt BO, Bilge U, Mollamahmutoglu L. Tumor Markers in Mature Cystic Teratomas of the Ovary. Arch Gynecol Obstet 2009; 279: 145-7
  3. Polat M, İncebıyık A, Şanvedi İ, Şenol T, Şentürk MB, Özkaya E, et al. Retrospective Analysis of 114 Cases Treated for Dermoid Cyst. Dicle Medical Journal 2016; 43: 256-60
  4. Park SB, Kim JK, Kim KR, Cho KS. Preoperative Diagnosis of Mature Cystic Teratoma with Malignant Transformation: Analysis of Imaging Findings Clinical and Laboratory Data. Arch Gynecol Obstet 2007; 275: 25-31
  5. Frimer M, Seagle BL, Chudnoff S, Goldberg GL, Shahabi S. Role of Elevated Cancer Antigen 19-9 in Women with Mature Cystic Teratoma. Reprod Sci 2014; 21: 1307-11
  6. Rezai S, Lieberman D, Raza A, Ferreira K, Henderson C, Sasken H. CA 19-9 Elevation in a Benign Ovarian Cystic Teratoma, A case Report and Review of Literature. Obstet Gynecol Int J 2017; 6: 207
  7. Kataoka T, Watanabe Y, Hoshiai H. Retrospective Evaluation of Tumor Markers in Ovarian Mature Cystic Teratoma And Ovarian Endometrioma. J Obstet Gynaecol Res 2012; 38: 1071-6
  8. Kim JY, Jee BC, Suh CS, Kim SH. Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma And Mature Cystic Teratoma. Yonsei Med J 2013; 54: 921-6
  9. Mohammed AA, Al-Hussaini TK, Fathalla MM, El Shamy TT, Abdelaal I, Amer SA. The Impact of Excision of Benign Nonendometriotic Ovarian Cysts on Ovarian Reserve: A Systematic Review. Am J Obstet Gynecol 2016; 215: 169-76
  10. Alammari R, Lightfoot M, Hur HC. Impact of Cystectomy on Ovarian Reserve: Review of the Literature. J Minim Invasive Gynecol 2017; 24: 247-57
  11. Yan L, Li M, Zhang BQ, Xu XX, Xu Z, Han T, et al. Effect of Ovarian Dermoid Cyst Excision on Ovarian Reserve and Response: Insights from in vitro Fertilization. Gynecology and Minimally Invasive Therapy 2016; 5: 161-5
  12. Chen TC, Kuo HT, Shyu SK, Chu CP, Chang TC. Endometriosis Coexisting with Dermoid Cyst in a Single Ovary: A Case Report. Chin Med J (Engl) 2011; 124: 627-30
  13. Prorocic M, Tasic L, Vasiljevic M, Jurisic A, Smiljkovic OD, Raznatovic S, et al. Smultaneous Dermoid Cyst and Endometross in the Same Ovary: A Case Report. Clin Exp Obstet Gynecol 2013; 40: 457-9
  14. Matalliotaki C, Matalliotakis M, Ieromonachou P, Goulielmos GN, Zervou MI, Laliotis A, et al. Co-existence of Benign Gynecological Tumors with